Bluemtec, a pharmaceutical e-commerce company, said it will start co-marketing two MSD’s vaccines -- one for hepatitis A the other for Measles, Mumps, and Rubella (MMR) –- in Korea from January 1, 2024.This marks the first joint vaccine sale between a local distributor and a global pharmaceutical co
Samil Pharmaceutical said Monday that its U.S. partner firm Biosplice Therapeutics confirmed the efficacy of Lorecivivint, a drug candidate for knee osteoarthritis, in a phase 3 study called OA-07. These results were recently revealed during the American College of Rheumatology (ACR) meeting held in
Novartis Korea said on Monday its biologic drug Cosentyx (secukinumab) will be covered by Korea’s national health insurance coverage as a first-line treatment for ankylosing spondylitis starting this month. According to the Ministry of Health and Welfare's directive, reimbursement for Cosentyx is ap
SLS Bio, a Kosdaq-listed developer of pharmaceuticals and diagnostic reagents, said it has entered into a contract with a global pharmaceutical company for the quality inspection and management testing of mRNA vaccines, without providing the name of the mutinational pharma. According to SLS Bio, the
Celltrion said Friday it submitted a marketing authorization application to the U.S. FDA for CT-P41, a biosimilar referencing Prolia (denosumab), aimed at treating osteoporosis and other related diseases.Prolia is an osteoporosis treatment developed by the multinational pharmaceutical giant Amgen. I
Daewoong Pharmaceutical said Friday that it has signed a contract with JSC Pharmasyntez, a Russian pharmaceutical company, to export diabetes drug Envlo (enavogliflozin) to Russia and five countries in the Commonwealth of Independent States (CIS) region.The contract is valued at approximately $60 mi
Pharmaceutical companies are trying to strengthen their competitiveness by combining original drug ingredients amid the competition for combination drugs to treat chronic diseases, such as hypertension and diabetes.On Tuesday, Handok received approval from the Ministry of Food and Drug Safety for it
GSK Korea said it conducted an internal campaign on Wednesday to improve awareness of human immunodeficiency virus (HIV) diseases in line with the upcoming "World AIDS (acquired immune deficiency syndrome) Day" on Dec. 1.World AIDS Day was established in January 1988 at the World Health Ministers' M
Ulcerative colitis, an incurable condition demanding continual therapeutic oversight marked by recurrent remissions and relapses, was discussed by Cheon Jae-hee, Professor of Gastroenterology at Severance Hospital, during a BMS Korea's media session on Wednesday."Ulcerative colitis requires treatmen
In the dynamic realm of pharmaceutical advancements, Merck has established itself as a global leader in infertility treatment, consistently setting new benchmarks through innovative therapies and groundbreaking research.Over recent years, Merck's commitment to addressing infertility has transformed
Daewoong Pharmaceutical said Wednesday it confirmed the safety of Dwj1563 in phase 1 clinical trials. Dwj1563 is a combination drug, mixing Envlo (enavogliflozin), designed to excrete sugar, with Zemiglo (gemigliptin), also known for its sugar-lowering properties.The phase 1 study served as a bioequ
Hanmi Pharm said Monday it has been selected as the No. 1 pharma company in the Korean Sustainability Index (KSI) for the fourth consecutive year at the “2023 Korea Sustainability Competition” organized by the Korea Standards Association (KSA).The KSI is an index that evaluates the sustainability of
JW Holdings said it has initiated the full-scale export of Winuf Central 736/1,085ml, a three-chamber total parenteral nutrition (TPN), to Mongolia through local pharmaceutical firm AsiaPharma LLC. TPN refers to the feeding of nutritional products to a person intravenously, bypassing the usual proce
Dong-A ST said Monday that it has received IND approval for a phase 1/2a clinical trial of its immuno-oncology drug, DA-4505, from the Ministry of Food and Drug Safety (MFDS), to treat solid tumors.The study will evaluate the safety and efficacy of DA-4505 monotherapy or in combination with the PD-1
Sillajen's shares shot up a daily limit of 30 percent to trade at 5,590 won ($4.3) on Monday afternoon, after filing on Friday results of a phase 1b/2a clinical study on Pexa-Vec, a thymidine kinase-deactivated vaccinia virus, combined with Regeneron's checkpoint inhibitor, Libtayo (cemiplimab), for
The Ministry of Food and Drug Safety (MFDS) said it has appealed against the first-instance court decision that canceled the sales suspension of Meditoxin, Medytox's botulinum toxin (BTX) product.The MFDS decided to appeal under the direction of the Ministry of Justice, believing that further respon
Kwangdong Pharmaceutical said Friday that it has signed a co-promotion agreement with MSD Korea on the human papillomavirus (HPV) vaccine Gardasil and Gardasil 9.Under the agreement, the two companies will jointly market and distribute Gardasil and Gardasil 9 in Korea starting January 1, 2024.Gardas
A petition has been posted to call for providing insurance benefits for Lilly's CDK 4&6 inhibitor Verzenio (abemaciclib) for early-stage breast cancer.Verzenio is the first CDK 4&6 inhibitor to have its indication expanded to include HR+ (hormone receptor positive)/HER2- (human epidermal growth fact
Novartis' PI3K-inhibiting breast cancer drug Piqray (alpelisib) has been struggling in the Korean market, failing to gain access to health insurance coverage.In the meantime, AstraZeneca recently launched a process to win approval in Korea with its FDA-approved AKT inhibitor, capivasertib (Truqap in
Bukwang Pharmaceutical said that the Ministry of Food and Drug Safety has approved Latuda Tab. (ingredient: Lurasidone Hydrochloride), a treatment for schizophrenia and major depressive episodes associated with bipolar I disorder developed by Japan's Sumitomo Pharma.Latuda acts as an antagonist by b